has the whole industrial chain of R&D, manufacturing, and commercialization. We provide more effective and accessible therapy and innovative medicines to fulfill global medical needs. Since 2017, an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation was established.
The IND Application for 6MW3511 Injection - An Innovative Drug from Mabwell is Accepted by NMPA
Achievements in Scientific Research | Mabwell Published ADE Mechanism of SARS-CoV-2 Neutralizing Antibodies in Communications Biology
Facilitate Development and Accelerate Progress | Zhangjiang Town Leaders Visit Mabwell Bioscience to Research and Guide Work
The IND Application of Mabwell Innovative Drug 8MW2311 for Injection was Accepted by NMPA